<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Adaptogenics Health Corp. — News on 6ix</title>
    <link>https://6ix.com/company/adaptogenics-health-corp</link>
    <description>Latest news and press releases for Adaptogenics Health Corp. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 05 May 2026 20:05:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/adaptogenics-health-corp" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836826878dffbe2df168e10.webp</url>
      <title>Adaptogenics Health Corp.</title>
      <link>https://6ix.com/company/adaptogenics-health-corp</link>
    </image>
    <item>
      <title>Adaptive Biotechnologies Reports First Quarter 2026 Financial Results</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-reports-first-quarter-2026-financial-results-1</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-reports-first-quarter-2026-financial-results-1</guid>
      <pubDate>Tue, 05 May 2026 20:05:00 GMT</pubDate>
      <description>SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (&amp;#x201C;Adaptive ...</description>
    </item>
    <item>
      <title>Adaptogenics Health Corp. Announces Strategic Review of Health &amp; Wellness Opportunities and Management Changes</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptogenics-health-corp-announces-strategic-review-of-health-and-wellness-opportunities-and-management-changes</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptogenics-health-corp-announces-strategic-review-of-health-and-wellness-opportunities-and-management-changes</guid>
      <pubDate>Fri, 01 May 2026 18:40:00 GMT</pubDate>
      <description>Vancouver, British Columbia--(Newsfile Corp. - May 1, 2026) - Adaptogenics Health Corp. (CSE: ADPT) (&quot;Adaptogenics&quot;, the &quot;Company&quot;) announces that its board of directors has initiated a strategic review to evaluate potential business opportunities within the broader health and wellness sector.As part of this review, the Company&apos;s board of directors and senior management are examining a range of potential strategic initiatives, which may include prospective business line transitions, strategic...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026-1</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026-1</guid>
      <pubDate>Wed, 15 Apr 2026 20:05:00 GMT</pubDate>
      <description>SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), ...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-reports-fourth-quarter-and-full-year-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
      <pubDate>Thu, 05 Feb 2026 21:05:00 GMT</pubDate>
      <description>SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (&amp;#x201C;Adaptive...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies to Participate in Upcoming Investor Conferences</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-participate-in-upcoming-investor-conferences</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-participate-in-upcoming-investor-conferences</guid>
      <pubDate>Tue, 27 Jan 2026 21:05:00 GMT</pubDate>
      <description>SEATTLE, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-5-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-5-2026</guid>
      <pubDate>Thu, 22 Jan 2026 21:05:00 GMT</pubDate>
      <description>SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-announces-preliminary-fourth-quarter-and-full-year-2025-results</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-announces-preliminary-fourth-quarter-and-full-year-2025-results</guid>
      <pubDate>Mon, 12 Jan 2026 12:30:00 GMT</pubDate>
      <description>SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-present-at-the-44th-annual-jp-morgan-healthcare-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-present-at-the-44th-annual-jp-morgan-healthcare-conference</guid>
      <pubDate>Tue, 30 Dec 2025 21:05:00 GMT</pubDate>
      <description>SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-announces-two-immune-receptor-licensing-agreements-with-pfizer</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-announces-two-immune-receptor-licensing-agreements-with-pfizer</guid>
      <pubDate>Mon, 15 Dec 2025 13:00:00 GMT</pubDate>
      <description>A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-participate-in-jefferies-fireside-chat-series-on-minimal-residual-disease</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-participate-in-jefferies-fireside-chat-series-on-minimal-residual-disease</guid>
      <pubDate>Tue, 09 Dec 2025 22:07:34 GMT</pubDate>
      <description>SEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ&amp;#xAE; Data Driving Treatment Interventions at 2025 ASH Annual Meeting</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-showcases-leadership-in-hematology-oncology-mrd-with-new-clonoseqandxae-data-driving-treatment-interventions-at-2025-ash-annual-meeting</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-showcases-leadership-in-hematology-oncology-mrd-with-new-clonoseqandxae-data-driving-treatment-interventions-at-2025-ash-annual-meeting</guid>
      <pubDate>Sat, 06 Dec 2025 13:30:00 GMT</pubDate>
      <description>SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ&amp;#xAE; MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-announces-nearly-90-abstracts-featuring-clonoseqandxae-mrd-testing-across-a-range-of-blood-cancers-to-be-presented-at-the-67th-ash-annual-meeting</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-announces-nearly-90-abstracts-featuring-clonoseqandxae-mrd-testing-across-a-range-of-blood-cancers-to-be-presented-at-the-67th-ash-annual-meeting</guid>
      <pubDate>Mon, 24 Nov 2025 12:30:00 GMT</pubDate>
      <description>SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-reports-third-quarter-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-reports-third-quarter-2025-financial-results</guid>
      <pubDate>Wed, 05 Nov 2025 21:05:00 GMT</pubDate>
      <description>SEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (&amp;#x201C;Adaptive...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-report-third-quarter-2025-financial-results-on-november-5-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-report-third-quarter-2025-financial-results-on-november-5-2025</guid>
      <pubDate>Wed, 15 Oct 2025 20:05:00 GMT</pubDate>
      <description>SEATTLE, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference</guid>
      <pubDate>Wed, 27 Aug 2025 20:05:00 GMT</pubDate>
      <description>SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-reports-second-quarter-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-reports-second-quarter-2025-financial-results</guid>
      <pubDate>Tue, 05 Aug 2025 20:05:00 GMT</pubDate>
      <description>SEATTLE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (&amp;#x201C;Adaptive...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-report-second-quarter-2025-financial-results-on-august-5-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-report-second-quarter-2025-financial-results-on-august-5-2025</guid>
      <pubDate>Tue, 15 Jul 2025 20:05:00 GMT</pubDate>
      <description>SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ&amp;#xAE; MRD Testing into OncoEMR&amp;#xAE;</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-and-flatiron-health-announce-integration-of-clonoseqandxae-mrd-testing-into-oncoemrandxae</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-and-flatiron-health-announce-integration-of-clonoseqandxae-mrd-testing-into-oncoemrandxae</guid>
      <pubDate>Tue, 01 Jul 2025 11:30:07 GMT</pubDate>
      <description>SEATTLE, July 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ&amp;#xAE; MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-highlights-new-data-at-2025-asco-annual-meeting-and-eha-2025-congress-demonstrating-how-clonoseqandxae-mrd-assessment-is-optimizing-patient-care-and-drug-development-in-lymphoid-cancers</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-highlights-new-data-at-2025-asco-annual-meeting-and-eha-2025-congress-demonstrating-how-clonoseqandxae-mrd-assessment-is-optimizing-patient-care-and-drug-development-in-lymphoid-cancers</guid>
      <pubDate>Fri, 30 May 2025 11:30:00 GMT</pubDate>
      <description>SEATTLE, May 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a ...</description>
    </item>
    <item>
      <title>Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference</title>
      <link>https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-participate-in-the-goldman-sachs-46th-annual-global-healthcare-conference</link>
      <guid isPermaLink="true">https://6ix.com/company/adaptogenics-health-corp/news/adaptive-biotechnologies-to-participate-in-the-goldman-sachs-46th-annual-global-healthcare-conference</guid>
      <pubDate>Wed, 28 May 2025 20:05:00 GMT</pubDate>
      <description>SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a ...</description>
    </item>
  </channel>
</rss>